Complications of recombinant activated human coagulation factor VII

American Journal of Surgery

Volumn 198, Issue 6, 2009, Pages 895-899

  Howes, Jeremy L ^a   Smith, R Stephen ^b   Helmer, Stephen D ^a   Taylor, Scott M ^c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^c Via Christi Regional Medical Center ^*  (United States)

Author keywords

Coagulopathy; Factor VII; Thrombosis; Trauma

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; RECOMBINANT BLOOD CLOTTING FACTOR 7A; WARFARIN;

ACUTE HEART INFARCTION; ADULT; ANTICOAGULATION; ARTERY THROMBOSIS; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DRUG FATALITY; EPIDURAL HEMATOMA; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HUMAN; INJURY SCALE; INTRAPARENCHYMAL HEMORRHAGE; ISCHEMIA; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; SEX RATIO; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; THROMBOEMBOLISM; THROMBOSIS; TRAUMATIC BRAIN INJURY; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; FACTOR VIIA; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; VENOUS THROMBOSIS; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 71149087738     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.05.026     Document Type: Article

References (16)

1. Bosch J., Thabut D., Bendtsen F., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127 (2004) 1123-1130
2. Friedrich P.W., Henny C.P., Messelink E.J., et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 361 (2003) 201-205
3. Lodge J.P., Jonas S., Oussoultzoglou E., et al. Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology 102 (2005) 269-275
4. Shao Y.F., Yang J.M., Chau G.Y., et al. Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Surg 191 (2006) 245-249
5. Raobaikady R., Redman J., Ball J.A., et al. Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial. Br J Anaesth 94 (2005) 586-591
6. Boffard K.D., Riou B., Warren B., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59 (2005) 8-18
7. Martinowitz U., Kenet G., Segal E., et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 51 (2001) 431-439
8. Monroe D.M., Hoffman M., Oliver J.A., et al. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99 (1997) 542-547
9. Erhardtsen E. Ongoing NovoSeven trials. Intensive Care Med 28 Suppl 2 (2002) S248-S255
10. Barletta J.F., Ahrens C.L., Tyburski J.G., et al. A review of recombinant factor VII for refractory bleeding in nonhemophilic trauma patients. J Trauma 58 (2005) 646-651
11. Harrison T.D., Laskosky J., Jazaecri O., et al. "Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage. J Trauma 59 (2005) 150-154
12. Thomas G.O., Dutton R.P., Hemlock B., et al. Thromboembolic complications associated with factor VIIa administration. J Trauma 62 (2007) 564-569
13. Brody D.L., Aiyagari V., Shackleford A.M., et al. Use of recombinant factor VIIa in patients with warfarin-associated intracerebral hemorrhage. Neurocrit Care 2 (2005) 263-267
14. Deveras R.A., and Kessler C.M. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 137 (2002) 884-888
15. Lin J., Hanigan W.C., Tarantino M., et al. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg 98 (2003) 737-740
16. Mayer S.A., Brun N.C., Begtrup K., et al. Efficacy and safety of recombinant activated Factor VII for acute intracerebral hemorrhage. N Engl J Med 358 (2008) 2127-2137